- Home
- SBFM vs TTNP Comparison
SBFM vs TTNP Comparison
Compare SBFM & TTNP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- TTNP
- Stock Information
- Founded
- SBFM 2006
- TTNP 1991
- Country
- SBFM United States
- TTNP United States
- Employees
- SBFM N/A
- TTNP N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SBFM Health Care
- TTNP Health Care
- Exchange
- SBFM Nasdaq
- TTNP Nasdaq
- Market Cap
- SBFM 3.7M
- TTNP 3.7M
- IPO Year
- SBFM N/A
- TTNP 1996
- Fundamental
- Price
- SBFM $2.35
- TTNP $3.81
- Analyst Decision
- SBFM
- TTNP
- Analyst Count
- SBFM 0
- TTNP 0
- Target Price
- SBFM N/A
- TTNP N/A
- AVG Volume (30 Days)
- SBFM 151.4K
- TTNP 8.5K
- Earning Date
- SBFM 11-05-2024
- TTNP 11-29-2024
- Dividend Yield
- SBFM N/A
- TTNP N/A
- EPS Growth
- SBFM N/A
- TTNP N/A
- EPS
- SBFM N/A
- TTNP N/A
- Revenue
- SBFM $32,959,491.00
- TTNP $3,000.00
- Revenue This Year
- SBFM $86.70
- TTNP N/A
- Revenue Next Year
- SBFM $126.76
- TTNP N/A
- P/E Ratio
- SBFM N/A
- TTNP N/A
- Revenue Growth
- SBFM 61.94
- TTNP N/A
- 52 Week Low
- SBFM $2.25
- TTNP $3.57
- 52 Week High
- SBFM $638.00
- TTNP $14.80
- Technical
- Relative Strength Index (RSI)
- SBFM 25.54
- TTNP 34.23
- Support Level
- SBFM $2.58
- TTNP $3.77
- Resistance Level
- SBFM $2.86
- TTNP $4.66
- Average True Range (ATR)
- SBFM 0.17
- TTNP 0.28
- MACD
- SBFM -0.04
- TTNP 0.04
- Stochastic Oscillator
- SBFM 12.67
- TTNP 3.93
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. The company is conducting a proprietary drug development program which is comprised of (i) K1.1 mRNA targeted for liver cancer, (ii) SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections, and (iii) Adva-27a for pancreatic cancer. The company has two reportable segments: Prescription Generic Pharmaceuticals ("Generic Pharmaceuticals") and Nonprescription Over-The-Counter Products ("OTC Products"). The company generates the majority of its revenue from the Generic Pharmaceuticals segment.
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.